Pearl Therapeutics Leases 14,695 SF at Royal Center I in Durham, NC

Cassidy Turley Represented Pearl Therapeutics in the Transaction

Published on February 14, 2013


RALEIGH, NC – Cassidy Turley, a leading commercial real estate services provider in the U.S., announced that Pearl Therapeutics leased 14,695 square feet of laboratory and office space in Royal Center I, located at 4222 Emperor Boulevard, in Durham, North Carolina.

Pearl Therapeutics is a Northern California headquartered life science company who has had a presence in the Raleigh-Durham area for many years.  This new space represents a significant move and expansion to accommodate the growing business.

Deborah Boucher, of Cassidy Turley’s Raleigh office represented the lessee, Pearl Therapeutics in the transaction.

"I have had the privilege of working with Pearl for many years and have seen them achieve consistent success that has led them to steady growth” stated Deborah. “I am thrilled to see them continue on this path with their new space."

About Pearl Therapeutics
Pearl Therapeutics is a privately held company developing combination therapies for the treatment of highly prevalent respiratory diseases, including chronic obstructive pulmonary disease and asthma. Pearl is rapidly advancing a pipeline of products including PT003, an inhaled, fixed-dose combination bronchodilator product comprised of a long-acting muscarinic antagonist (LAMA) and a long-acting beta 2 agonist (LABA) delivered via a metered dose inhaler (HFA MDI); and PT010, a triple-combination product that combines the LAMA and LABA components of PT003 with an inhaled corticosteroid (ICS) for twice-daily administration from an HFA MDI for the treatment of severe COPD. Both PT003 and PT010 are developed with Pearl’s proprietary porous particle co suspension technology, which allows the formulation of multiple products in the MDI format, with highly stable, robust and aerodynamically efficient drug delivery. Founded in 2006, Pearl Therapeutics is privately held and backed by 5AM Ventures, Clarus Ventures, New Leaf Ventures and Vatera Healthcare. For more information, please visit www.pearltherapeutics.com. 


About Cassidy Turley 
         

Cassidy Turley is a leading commercial real estate services provider with more than 3,700 professionals in more than 60 offices nationwide. The company represents a wide range of clients—from small businesses to Fortune 500 companies, from local non-profits to major institutions. The firm completed transactions valued at $22 billion in 2011, manages 455 million square feet on behalf of institutional, corporate and private clients and supports more than 28,000 domestic corporate services locations. Cassidy Turley serves owners, investors and tenants with a full spectrum of integrated commercial real estate services—including capital markets, tenant representation, corporate services, project leasing, property management, project and development services, and research and consulting. Cassidy Turley enhances its global service delivery outside of North America through a partnership with GVA, giving clients access to commercial real estate professionals in 65 international markets. Please visit www.cassidyturley.com for more information about Cassidy Turley. ###                   

 

Courtney Lewis
919.789.4255

 

 

More Recent Press Releases

  • No results to display...